/PRNewswire/ P2 Science Inc., a leading green chemistry company, announced today the close of a funding round led by Lewis & Clark AgriFood. In the round,.
/PRNewswire/ Even with the ever-changing situation, technological innovation is still the most critical component for biopharmaceutical companies long-term.
– CBX-12 has potential to improve efficacy and reduce toxicity over systemic topoisomerase inhibitors –– Deal reflects Exelixis’ strategic focus on expanding its clinical pipeline and building upon its growing biotherapeutics expertise –ALAMEDA, Calif. & NEW HAVEN, Conn. (BUSINESS WIRE) Exelixis, Inc. (Nasdaq: EXE.